Moreover, pretreatment with a specific inhibitor of MEK, p38MAPK, and PI3K suppressed chemerin-induced IL-6 production, and p38 MAPK and PI3 kinase inhibitor reduced RA FLS cell motility. The gene discussed is IL6; the disease is rheumatoid arthritis.